扩散加权乳腺MRI预测活检证实的导管原位癌患者术后分期升级
本研究在140例活检证实的导管原位癌患者中开发基于术前3.0-T乳腺MRI(含DCE和DWI)的预测模型,并在105例前瞻性内部验证集中验证,模型联合DWI与临床病理因素预测分期升级的AUC在开发集为0.87、验证集为0.76,预测浸润癌概率的观察者间一致性良好(ICC 0.79)。
要点
- 联合DWI与临床病理因素的模型预测DCIS术后分期升级,开发集AUC 0.87、验证集AUC 0.76。
- 预测浸润癌概率的观察者间一致性良好(ICC 0.79),阳性预测值85%、阴性预测值92%。
- 开发集与验证集分期升级率均为41%(57/140与43/105)。
核心结论
- 基于扩散加权乳腺MRI的预测模型可识别高分期升级风险的DCIS女性。
研究设计与样本
- 回顾性开发集(2019年6月至2020年3月)140例连续活检证实的DCIS女性,前瞻性内部验证集(2020年7月至2021年4月)105例,均行术前3.0-T乳腺MRI含DCE与DWI,以手术病理确定浸润癌及腋窝转移。
关键影像表现/征象
- 收集DWI病灶表观扩散系数、DCE MRI病灶大小与形态特征、钼靶表现、年龄、症状、活检方式及活检DCIS分级。
诊断标准与关键数值
- 预测模型联合DWI与临床病理因素,预测分期升级的AUC开发集0.87(95%CI 0.80, 0.92)、验证集0.76(95%CI 0.67, 0.84)。
- 预测浸润癌概率的观察者间一致性ICC 0.79,阳性预测值85%(28/33),阴性预测值92%(22/24)。
临床应用与阅片要点
- 原文结论为基于扩散加权乳腺MRI的预测模型识别了高分期升级风险女性,并指出该模型用于筛选可能在初次手术中受益于前哨淋巴结活检的高危女性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Accurate preoperative prediction of upstaging in women with biopsy-proven ductal carcinoma in situ (DCIS) is important for surgical planning, but published models using predictive MRI features remain lacking. Purpose To develop and validate a predictive model based on preoperative breast MRI to predict upstaging in women with biopsy-proven DCIS and to select high-risk women who may benefit from sentinel lymph node biopsy at initial surgery. Materials and methods Consecutive women with biopsy-proven DCIS who underwent preoperative 3.0-T breast MRI including dynamic contrast-enhanced (DCE) MRI and diffusion-weighted imaging (DWI) and who underwent surgery between June 2019 and March 2020 were retrospectively identified (development set) from an academic medical center. The apparent diffusion coefficients of lesions from DWI, lesion size and morphologic features on DCE MRI scans, mammographic findings, age, symptoms, biopsy method, and DCIS grade at biopsy were collected. The presence of invasive cancer and axillary metastases was determined with surgical pathology. A predictive model for upstaging was developed by using multivariable logistic regression and validated in a subsequent prospective internal validation set recruited between July 2020 and April 2021. Results Fifty-seven (41%) of 140 women (mean age, 53 years ± 11 [SD]) in the development set and 43 (41%) of 105 women (mean age, 53 years ± 10) in the validation set were upstaged after surgery. The predictive model combining DWI and clinical-pathologic factors showed the areas under the receiver operating characteristic curve at 0.87 (95% CI: 0.80, 0.92) in the development set and 0.76 (95% CI: 0.67, 0.84) in the validation set. The predicted probability of invasive cancer showed good interobserver agreement (intraclass correlation coefficient, 0.79); the positive predictive value was 85% (28 of 33), and the negative predictive value was 92% (22 of 24). Conclusion A predictive model based on diffusion-weighted breast MRI identified women at high risk of upstaging. © RSNA, 2022 Online supplemental material is available for this article See also the editorial by Baltzer in this issue. An earlier incorrect version appeared online. This article was corrected on July 7, 2022.
引用
- Lee, Lee, Ryu, et al. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ. Radiology. 2022. PMID: 35787199. doi:10.1148/radiol.213174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。